IRON vs VRTX: Which Stock is Better?
Side-by-side comparison of Disc Medicine Inc and Vertex Pharmaceuticals Inc in 2026
IRON
Disc Medicine Inc
$70.18
VRTX
Vertex Pharmaceuticals Inc
$441.70
Key Metrics Comparison
| Metric | IRON | VRTX | Winner |
|---|---|---|---|
| Market Cap | $2.69B | $113.01B | VRTX |
| P/E Ratio | N/A | 28.98 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze IRON
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRON or VRTX a better investment?
Comparing IRON and VRTX: Disc Medicine Inc has a market cap of $2.69B while Vertex Pharmaceuticals Inc has $113.01B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRON and VRTX?
IRON (Disc Medicine Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRON or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRON or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for IRON.
Which company is more profitable: IRON or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for IRON.
Which is the larger company: IRON or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.01B compared to $2.69B for IRON.
Should I buy IRON or VRTX in 2026?
Both IRON and VRTX have investment merit. IRON trades at $70.18 while VRTX trades at $441.70. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRON and VRTX stock?
Key differences: Market Cap ($2.69B vs $113.01B), P/E Ratio (N/A vs 29.0x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).